efficacy and safety of non vitamin K anticoagulants compared to vitamin K anticoagulants in treatment of atrial fibrillation patients
Not Applicable
- Conditions
- Health Condition 1: I489- Unspecified atrial fibrillation and atrial flutter
- Registration Number
- CTRI/2022/05/042669
- Lead Sponsor
- srm college of pharmacy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Atrial fibrillation patients
Exclusion Criteria
Patient with anitcoagulant therapy for a condition other than AF n
Pregnant and lactating women.
Patient with liver disease ( acute clinical hepatitis , chronic active hepatitis , cirrhosis )
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PT , INR Normal values indicate that patient is at lower risk of stroke .Timepoint: 3 months once
- Secondary Outcome Measures
Name Time Method There is a significant risk of intracranial bleeding, GI bleeding in patients , GARFIELD - AF Score is used to asses this risk.Timepoint: 6 months once